An erythroid differentiation signature predicts response to lenalidomide in Myelodysplastic Syndrome

No citation available. Published: 2008.01.31

Benjamin L. Ebert, Naomi Galili, Pablo Tamayo, Jocelyn Bosco, Raymond Mak, Jennifer Pretz, Christine Ladd-Acosta, Richard Stone, Todd R. Golub and Azra Raza.

Abstract

No abstract available

Keywords: Myelodysplastic Syndrome (MDS) erythroid differentiation hematopoietic disorder lenalidomide revlimid

Hm

Supplemental Data

Description Link/Filename
Datasets files and prediction program (R script) Revlimid_files_and_program.zip
Sample annotation file journal.pmed.0050035.st001.xls
CEL files revlimid_files (1).zip